Chinese General Practice ›› 2019, Vol. 22 ›› Issue (22): 2755-2759.DOI: 10.12114/j.issn.1007-9572.2019.00.420
Special Issue: 泌尿系统疾病最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:
2019-08-05
Online:
2019-08-05
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2019.00.420
[1]LEVIN A,STEVENS P E,BILOUS R W,et al.Kidney Disease Improving Global Outcomes(KDIGO) CKD Work Group.KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J].Kidney International Supplements,2013,3(1):1-150. [2]BELLO A K,LEVIN A,TONELLI M,et al.Assessment of global kidney health care status[J].JAMA,2017,317(18):1864-1881.DOI:10.1001/jama.2017.4046. [3]MILLS K T,XU Y,ZHANG W D,et al.A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010[J].Kidney Int,2015,88(5):950-957.DOI:10.1038/ki.2015.230. [4]MATHEW T,CORSO O.Review article:early detection of chronic kidney disease in Australia:which way to go[J].Nephrology(Carlton),2009,14(4):367-373.DOI:10.1111/j.1440-1797.2009.01113.x. [5]郑法雷.慢性肾脏疾病筛查的必要性和实施方法[J].诊断学理论与实践,2007,6(6):475-477.DOI:10.3969/j.issn.1671-2870.2007.06.001. ZHENG F L.Necessity and implement methods of screening chronic kidney disease[J].Journal of Diagnostics Concepts & Practice,2007,6(6):475-477.DOI:10.3969/j.issn.1671-2870.2007.06.001. [6]JHA V,GARCIA-GARCIA G,ISEKI K,et al.Chronic kidney disease:global dimension and perspectives[J].Lancet,2013,382(9888):260-272.DOI:10.1016/S0140-6736(13)60687-X. [7]GOLESTANEH L,ALVAREZ P J,REAVEN N L,et al.All-cause costs increase exponentially with increased chronic kidney disease stage[J].Am J Manag Care,2017,23(10 suppl):s163-172. [8]JOMMI C,ARMENI P,BATTISTA M,et al.The cost of patients with chronic kidney failure before dialysis:results from OST of patients with chronic kidney failure before dialysis:results from the IRIDE observational study[J].Pharmacoecon Open,2018,2(4):459-467.DOI:10.1007/s41669-017-0062-z. [9]ZHANG L,WANG F,WANG L,et al.Prevalence of chronic kidney disease in China:across-sectional survey[J].The Lancet,2012,379(9818):815-822.DOI:10.1016/S0140-6736(12)60033-6. [10]GALBRAITH L,HEMMELGARN B,MANNS B,et al.The association between individual counselling and health behaviour change:the See Kidney Disease(SeeKD) targeted screening programme for chronic kidney disease[J].Can J Kidney Health Dis,2016,3:35.DOI:10.1186/s40697-016-0127-4. [11]ZHANG L X,LONG J Y,JIANG W S,et al.Trends in chronic kidney disease in China[J].N Engl J Med,2016,375(9):905-906.DOI:10.1056/NEJMc1602469. [12]JOHNSON D W.Evidence-based guide to slowing the progression of early renal in sufficiency[J].Internal Medicine Journal,2004:50-57.DOI:10.1111/j.1444-0903.2004.t01-6-x. [13]VAN DER VELDE M,HALBESMA N,DE CHARRO F T,et al.Screening for albuminuria identifies individuals at increased renal risk[J].J Am Soc Nephrol,2009,20(4):852-862.DOI:10.1681/ASN.2008060655. [14]QASEEM A,HOPKINS R H,SWEET D E,et al.Screening,monitoring,and treatment of stage 1 to 3 chronic kidney disease:a clinical practice guideline from the American College of Physicians[J].Ann Intern Med,2013,159(12):835-847.DOI:10.7326/0003-4819-159-12-201312170-00726. [15]LAVALLEE B,CHARTRAND C,MCLEOD L,et al.Mass screening for chronic kidney disease in rural and remote Canadian first nations people:methodology and demographic characteristics[J].Canadian Journal of Kidney Health and Disease,2015,2(1):1-10.DOI:10.1186/s40697-015-0046-9. [16]上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.DOI:10.19538/j.nk2017010108. Expert Group on Early Detection,Diagnosis and Treatment System Construction of Chronic Kidney Disease in Shanghai.Guideline for screening,diagnosis,prevention and treatment of chronic kidney disease[J].Chinese Journal of Practical Internal Medicine,2017,37(1):28-34.DOI:10.19538/j.nk2017010108. [17]GO D S,KIM S H,PARK J,et al.Cost-utility analysis of the National Health Screening Program for chronic kidney disease in Korea[J].Nephrology(Carlton),2019,24(1):56-64.DOI:10.1111/nep.13203. [18]KOMENDA P,FERGUSON T W,MACDONALD K,et al.Cost-effectiveness of primary screening for CKD:a systematic review[J].Am J Kidney Dis,2014,63(5):789-797.DOI:10.1053/j.ajkd.2013.12.012. [19]MANNS B,HEMMELGARN B,TONELLI M,et al.Population based screening for chronic kidney disease:cost effectiveness study[J].BMJ,2010,341:c5869.DOI:10.1136/bmj.c5869. [20]JOHNSON D W,ATAI E,CHAN M,et al.KHA-CARI guideline:early chronic kidney disease:detection,prevention and management[J].Nephrology,2013,18(5):340-350.DOI:10.1111/nep.12052. [21]National Clinical Guideline Centre(UK).Chronic kidney disease(partial update):early identification and management of chronic kidney disease in adults in primary and secondary care [EB/OL].[2019-01-10].https://www.nice.org.uk/. [22]Ministry of Health.Chronic kidney disease:identification,evaluation and management of adult patients[EB/OL].[2019-01-10].https://www2.gov.bc.ca/assets/gov/health/practitioner-pro/bc-guidelines/ckd-full-guideline.pdf. [23]Ministry of Health.Managing chronic kidney disease in primary care:national consensus statement[EB/OL].[2019-01-10].https://www.health.govt.nz/system/files/documents/publications/managing-chronic-kidney-disease-primary-care-mar15-v2.pdf. [24]GEORGE C,MOGUEO A,OKPECHI I,et al.Chronic kidney disease in low-income to middle-income countries:the case for increased screening[J].BMJ Glob Health,2017,2(2):e000256.DOI:10.1136/bmjgh-2016-000256. [25]FLOOD D,GARCIA P,DOUGLAS K,et al.Screening for chronic kidney disease in a community-based diabetes cohort in rural Guatemala:a cross-sectional study[J].BMJ Open,2018,8(1):e019778.DOI:10.1136/bmjopen-2017-019778. [26]GHEEWALA P A,ZAIDI S T R,JOSE M D,et al.Effectiveness of targeted screening for chronic kidney disease in the community setting:a systematic review[J].J Nephrol,2018,31(1):27-36.DOI:10.1007/s40620-017-0375-0. [27]HOWARD K,SALKELD G,WHITE S L,et al.Thecost-effectiveness of early detection and intervention to prevent the progression of chronic kidney disease in Australia[M].Melbourne:Kidney Health Australia,2006. [28]OLMOS R D.Screening for chronic kidney disease and inequity[J].Sao Paulo Med J,2016.DOI:10.1590/1516-3180.2016.0082080516. [29]BOCHUD M.On the rationale of population screening for chronic kidney disease:a public health perspective[J].Public Health Rev,2015,36:11.DOI:10.1186/s40985-015-0009-9. [30]MOYER V A.Screening for chronic kidney disease:US preventive services task force recommendation statement[J].Ann Intern Med,2012,157(8):567-570.DOI:10.7326/0003-4819-157-8-201210160-00533. [31]潘玉静,张路霞.估算肾小球滤过率的评价方法[J].中华内科杂志,2016,55(3):237-240.DOI:10.3760/cma.j.issn.0578-1426.2016.03.019. PAN Y J,ZHANG L X.Evaluation method for estimating glomerular filtration rate[J].Chinese Journal of Internal Medicine,2016,55(3):237-240.DOI:10.3760/cma.j.issn.0578-1426.2016.03.019. [32]KLAHR S,LEVEY A S,BECK G J,et al.The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease.Modification of Diet in Renal Disease Study Group[J].N Engl J Med,1994,330(13):877-884.DOI:10.1056/NEJM199403313301301. [33]RATNAYAKE S,BADURDEEN Z,NANAYAKKARA N,et al.Screening for chronic kidney disease of uncertain aetiology in Sri Lanka:usability of surrogate biomarkers over dipstick proteinuria[J].BMC Nephrol,2017,18(1):199.DOI:10.1186/s12882-017-0610-x. [34]PEREZMONTEOLIVA N R,FELIX F J,LOZANO L,et al.The HUGE formula(hematocrit,urea,sex) for screening chronic kidney disease(CKD) in an age-stratified general population[J].Journal of Nutrition Health & Aging,2015,19(6):688-692.DOI:10.1007/s12603-015-0504-1. [35]PHAM T A.Validation of the salivary urea and creatinine tests as screening methods of chronic kidney disease in Vietnamese patients[J].Acta Odontol Scand,2017,75(8):551-556.DOI:10.1080/00016357.2017.1356467. [36]MAO F,LIU S Y,QIAO X N,et al.Sudoscan,an effective tool for screening chronic kidney disease in patients with type 2 diabetes[J].Exp Ther Med,2017,14(2):1343-1350.DOI:10.3892/etm.2017.4689. [37]SAXENA A,GUPTA A,ABRAHAM G,et al.Non-invasive screening tool for chronic kidney disease[J].Saudi J Kidney Dis Transpl,2015,26(6):1311-1313.DOI:10.4103/1319-2442.168697. [38]WANG H Y,YANG L,WANG F,et al.Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease[J].BMC Nephrol,2017,18(1):135.DOI:10.1186/s12882-017-0538-1. [39]BANG H,MAZUMDAR M,NEWMAN G,et al.Screening for kidney disease in vascular patients:Screening for Occult Renal Disease(SCORED) experience[J].Nephrol Dial Transplant,2009,24(8):2452-2457.DOI:10.1093/ndt/gfp124. [40]ASHTON C W,DUFFIE D.Chronic kidney disease in Canada's First Nations:results of an effective cross-cultural collaboration[J].Healthc Q,2011,14(3):42-47. [41]CURTIS C,BALINT C,AL HAMARNEH Y N,et al.Online clinical pathway for managing adults with chronic kidney disease[J].Can Pharm J(Ott),2015,148(5):257-262.DOI:10.1177/1715163515597243. [42]SAMAL L,D'AMORE J D,BATES D W,et al.Implementation of a scalable,web-based,automated clinical decision support risk-prediction tool for chronic kidney disease using C-CDA and application programming interfaces[J].J Am Med Inform Assoc,2017,24(6):1111-1115.DOI:10.1093/jamia/ocx065. [43]PERALTA C A,FRIGAARD M,RUBINSKY A D,et al.Implementation of a pragmatic randomized trial of screening for chronic kidney disease to improve care among non-diabetic hypertensive veterans[J].BMC Nephrol,2017,18(1):132.DOI:10.1186/s12882-017-0541-6. [44]WONG D,CAO S,FORD H,et al.Exploring the use of tablet computer-based electronic data capture system to assess patient reported measures among patients with chronic kidney disease:a pilot study[J].BMC Nephrol,2017,18(1):356.DOI:10.1186/s12882-017-0771-7. [45]牛娜,董建琴,杜雪平.北京市基层全科医生对慢性肾脏病的认知调查[J].中国全科医学,2017,20(10):1267-1270.DOI:10.3969/j.issn.1007-9572.2017.10.025. NIU N,DONG J Q,DU X P.Cognition of grass-roots general practitioners on chronic kidney disease in Beijing[J].Chinese General Practice,2017,20(10):1267-1270.DOI:10.3969/j.issn.1007-9572.2017.10.025. [46]GEORGE P P,OH C M,LOH P T,et al.Right-siting chronic kidney disease care-a survey of general practitioners in Singapore[J].Ann Acad Med Singap,2013,42(12):646-656. [47]TONKIN-CRINE S,SANTER M,LEYDON G M,et al.GPs' views on managing advanced chronic kidney disease in primary care:a qualitative study[J].Br J Gen Pract,2015,65(636):e469-477.DOI:10.3399/bjgp15X685693. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||